相关实验视频

Updated: May 7, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

RAD54L是一种预后生物标志物,在肝细胞癌中与药物敏感性有相关性

Tingting You^1,2, Hui Tang^1,2, Hui Ge¹

¹Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Cell biology international

|July 5, 2025

概括

高RAD54L表达表明肝细胞癌 (HCC) 的预后不佳. 向RAD54L可能会改善HCC患者的凝丁治疗疗效.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

肝细胞癌 (HCC) 具有侵略性和不良预后,对癌症死亡率有显著的贡献.
一种DNA修复蛋白质RAD54L正在研究其在HCC进展中的作用以及作为潜在的预后标记物.

研究的目的:

研究RAD54L在肝细胞癌 (HCC) 进展中的作用.
评估RAD54L作为HCC的预后标志物.
探索针对HCC中RAD54L的治疗潜力.

主要方法:

使用癌症基因组图谱和基因表达综合数据库进行RAD54L表达分析.
卡普兰-梅尔生存曲线和多变量考克斯回归用于预后评估.
进行了功能丰富,PPI网络和药物敏感性分析.

主要成果:

与正常肝脏样本相比,HCC组织中的RAD54LmRNA水平显著上调.
在HCC患者中,高RAD54L表达与较差的整体存活率和无病间隔相关.
RAD54L敲击降低了HepG2细胞的增殖,并增加了对gemcitabine的敏感性.

结论:

增加RAD54L表达与HCC的不良预后有关.
在HCC管理中,RAD54L显示出作为预后生物标志物和治疗点的潜力.
向RAD54L可能会增强对HCC的凝治疗的疗效.

关键词:

在RAD54L中,使用RAD54L.生物标志物生物标志物药物敏感性药物敏感性肝细胞癌是肝细胞癌.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...